Sodium bicarbonate

Generic Name
Sodium bicarbonate
Brand Names
Alka-seltzer, Alka-seltzer Fruit Chews, Alka-seltzer Heartburn Relief, Bi-peglyte, Bibag, Bicart, Bss Ophthalmic Solution, Ceo-two, Colyte, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hema Bp-38, Hemacart, Konvomep, Nulytely, Peglyte, Phoxillum, Physioneal 40, Prismasol, Zegerid, Zegerid Reformulated Aug 2006, Zegerid With Magnesium Hydroxide
Drug Type
Small Molecule
Chemical Formula
CHNaO3
CAS Number
144-55-8
Unique Ingredient Identifier
8MDF5V39QO
Background

Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.

Indication

Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significan...

Associated Conditions
Barbiturate intoxication, Breast Cancer, Constipation, Dental Decay, Duodenal Ulcer, Dyspepsia, Gastro-esophageal Reflux Disease (GERD), Gingival Bleeding, Heartburn, Helicobacter Infections, Hyperkalemia, Ischaemia, Metabolic Acidosis, Myocardial Infarction, Plaque, Dental, Pruritis of the skin, Skin Irritation, Upper GI Bleeding, Upset stomach, Zollinger-Ellison Syndrome, Abdominal bloating, Benign, active Gastric Ulcer, Methyl alcohol poisoning, Prophylaxis of Contrast-induced nephropathy, Salicylate poisoning, Severe Diarrhea, Swelling of the gums
Associated Therapies
Bowel preparation therapy

The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects

First Posted Date
2011-09-26
Last Posted Date
2011-10-12
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
30
Registration Number
NCT01440478
Locations
🇬🇧

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds, United Kingdom

Sodium Bicarbonate in Cardiopulmonary Resuscitation

Phase 4
Conditions
Interventions
First Posted Date
2011-06-21
Last Posted Date
2011-11-08
Lead Sponsor
Rambam Health Care Campus
Target Recruit Count
2130
Registration Number
NCT01377337
Locations
🇮🇱

Rambam Medical Center, Haifa, Israel

🇮🇱

Magen David Adom, Tel Aviv, Israel

Blood Gas Analysis and Buffering In Cardiac Arrest

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-05-30
Last Posted Date
2014-06-03
Lead Sponsor
Medical University of Graz
Target Recruit Count
700
Registration Number
NCT01362556
Locations
🇦🇹

LKH Graz West, Graz, Styria, Austria

🇦🇹

Landeskrankenhaus Klagenfurt, Klagenfurt, Carinthia, Austria

🇦🇹

Landesklinikum Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria

and more 3 locations

Study of Sodium Bicarbonate in Kidney Transplant Recipients

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-10-21
Last Posted Date
2016-04-06
Lead Sponsor
University of Utah
Target Recruit Count
29
Registration Number
NCT01225796
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Anesthetized Children

First Posted Date
2010-10-13
Last Posted Date
2010-10-28
Lead Sponsor
Sheba Medical Center
Target Recruit Count
30
Registration Number
NCT01219322
Locations
🇮🇱

Sheba Medical Center, Tel Hashomer, Israel

Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-07-29
Last Posted Date
2014-02-19
Lead Sponsor
Hospital Sao Lucas da PUCRS
Target Recruit Count
301
Registration Number
NCT01172353
Locations
🇧🇷

São Lucas Hospital - PUCRS University, Porto Alegre, RS, Brazil

Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction

First Posted Date
2010-07-12
Last Posted Date
2013-03-22
Lead Sponsor
Odense University Hospital
Target Recruit Count
720
Registration Number
NCT01160627
Locations
🇩🇰

Odense University Hospital, Odense, Denmark

Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED)

First Posted Date
2010-02-26
Last Posted Date
2015-03-11
Lead Sponsor
Bayer
Target Recruit Count
30
Registration Number
NCT01077076

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-11-01
Last Posted Date
2015-03-11
Lead Sponsor
Bayer
Target Recruit Count
63
Registration Number
NCT01005719

Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography

First Posted Date
2009-07-31
Last Posted Date
2009-07-31
Lead Sponsor
CardioVascular Research Foundation, Korea
Target Recruit Count
368
Registration Number
NCT00950079
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

🇰🇷

Busan Saint Mary Hospital, Busan, Korea, Republic of

🇰🇷

Chungnam National University Hospital, Daejeon, Korea, Republic of

and more 6 locations
© Copyright 2024. All Rights Reserved by MedPath